4DMedical Ltd (AU:4DX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
4DMedical Ltd has announced a change in the interests of its director, Andreas Fouras, with the acquisition of 775,339 unlisted options at an exercise price of $0.7534. These changes indicate a significant increase in Fouras’s stake, reflecting potential confidence in the company’s future performance. This update may interest investors keeping an eye on insider movements in the market.
For further insights into AU:4DX stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Nvidia Stock Could Take a Beating from Supply Snags on Blackwell Chips
- ‘This Is Just Pure Hype,’ Says Top Investor About Tesla Stock
- Will Palantir Stock Crash to $28? Jefferies Sounds the Alarm
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
